Chemed Corp. Hits New 52-Week High at USD 493.05

Chemed Corp. has reached a significant milestone by hitting a new 52-week high of USD 493.05 on July 10, 2026. This achievement highlights the stock's notable activity within the hospital industry, where Chemed operates as a small-cap company with a market capitalization of USD 12,841 million. Despite the recent high, Chemed Corp. has experienced a 1-year performance decline of 10.32%, contrasting sharply with the S&P 500's gain of 20.62% over the same period. The company's price-to-earnings (P/E) ratio stands at 48.00, indicating a premium valuation relative to its earnings. Additionally, Chemed boasts a return on equity of 27.10%, reflecting strong profitability relative to shareholder equity. The stock's dividend yield is currently at 0.27%, and it maintains a debt-to-equity ratio of -0.02, suggesting a conservative approach to leverage. The price-to-book ratio is noted at 13.11, further emphasizing its valuation metrics. Overall, Chemed Corp.'s recent performance and financial indicators present a complex picture within the hospital sector.